Drug recall · March 1, 2017
Transderm Scop recall
Why: Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540.
- Lots / codes
Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19
- Quantity
- 157,922 cartons
- Company
- Sandoz Inc, Princeton, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- February 2, 2017 · Voluntary: Firm initiated
- Classified
- February 17, 2017
- Reported
- March 1, 2017
- Ended
- October 24, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Scopolamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.